Software pioneer sees brighter fiscal results in ’02Most observers knew it has been a difficult year for Cedara Software, but the company made it official last week, announcing a net loss of $45.5 million, or $2.68 per share,
Software pioneer sees brighter fiscal results in ’02
Most observers knew it has been a difficult year for Cedara Software, but the company made it official last week, announcing a net loss of $45.5 million, or $2.68 per share, in the fourth quarter and $67.8 million for fiscal year 2001. The quarterly loss compared with a net loss of $7.3 million, or 47¢ per share, in the fourth quarter of 2000 and $6.6 million for the entire fiscal year 2000.
Cedara, whose products facilitate image-guided therapy and image management, also reported a net loss from continuing operations of $11.9 million, up from a net loss of $3.8 million in the fourth quarter of 2000. Annualized, the net loss from continuing operations totaled $26.3 million, up sharply from a net loss of $3.3 million in 2000.
On the bright side, revenues from continuing operations totaled nearly $14 million in the quarter, up from about $8 million in the fourth quarter of 2000. Record revenues of $46.7 million were reported for the fiscal year.
Consolidations within the PACS sector stalled the sales efforts of many of Cedara’s customers, which had an impact on Cedara’s sales performance, said Michael Greenberg, chair and chief executive officer. Additionally, higher than anticipated costs totaling $2.5 million for its only fixed-price development contract affected profitability. And Cedara subsidiary Surgical Navigation Specialists experienced a major product release delay just as its sales arm and 20% co-owner exited from the business, resulting in heavy losses.
The company has since moved to turn its operation around. Six executive positions were eliminated and the payroll was cut 35%. Arun Menawat was named president and chief operating officer in charge of day-to-day operations. And Analogic invested heavily in Cedara.
“The market fundamentals remain sound, our customers continue to look for cost-effective solutions, and our relationships continue to expand,” Menawat said. “Our cost position is substantially improved. On this basis I remain cautiously optimistic for the long-term future of this company.”
Four Strategies to Address the Tipping Point in Radiology
January 17th 2025In order to flip the script on the impact of the radiology workforce shortage, radiology groups and practices need to make sound investments in technologies and leverage partnerships to mitigate gaps in coverage and maximize workflow efficiencies.
Can Generative AI Facilitate Simulated Contrast Enhancement for Prostate MRI?
January 14th 2025Deep learning synthesis of contrast-enhanced MRI from non-contrast prostate MRI sequences provided an average multiscale structural similarity index of 70 percent with actual contrast-enhanced prostate MRI in external validation testing from newly published research.
Can MRI-Based AI Enhance Risk Stratification in Prostate Cancer?
January 13th 2025Employing baseline MRI and clinical data, an emerging deep learning model was 32 percent more likely to predict the progression of low-risk prostate cancer (PCa) to clinically significant prostate cancer (csPCa), according to new research.